In Swiss-EU relations, is the era of cordiality over? Read more: In Swiss-EU relations, is the era of cordiality over?
How trustworthy is Switzerland as an international mediator or go-between today? Read more: How trustworthy is Switzerland as an international mediator or go-between today?
Democrat disarray, mega-IPOs, and the pope takes a pop at Silicon Valley Read more: Democrat disarray, mega-IPOs, and the pope takes a pop at Silicon Valley
How do autocracies and dictatorships come to an end? Read more: How do autocracies and dictatorships come to an end?
Staying in neutral? How Swiss and Irish debates compare Read more: Staying in neutral? How Swiss and Irish debates compare
Gigantic new CERN collider aims to unlock secrets of universe Read more: Gigantic new CERN collider aims to unlock secrets of universe
Swiss finance under scrutiny over climate impact Read more: Swiss finance under scrutiny over climate impact
Should Switzerland prepare for a severe drought this summer? Read more: Should Switzerland prepare for a severe drought this summer?
The Swiss Connection Podcast: Hear Swiss science stories for the world Read more: The Swiss Connection Podcast: Hear Swiss science stories for the world
Blatten: ‘We lost everything, but not the joy of making music’ Read more: Blatten: ‘We lost everything, but not the joy of making music’
Hypnotic documentary lays bare Persian Gulf’s climate inequality Read more: Hypnotic documentary lays bare Persian Gulf’s climate inequality
Hong Kong overtakes Switzerland as hub for global offshore wealth Read more: Hong Kong overtakes Switzerland as hub for global offshore wealth
Swiss giant battery developer taps UK tech to feed AI power boom Read more: Swiss giant battery developer taps UK tech to feed AI power boom
To what extent do you think assisted suicide should be a legally available option to those who want to end their lives? Read more: To what extent do you think assisted suicide should be a legally available option to those who want to end their lives?
AI’s next pharma challenge: tackling costly and risky clinical trials Read more: AI’s next pharma challenge: tackling costly and risky clinical trials
Novartis buys Avidity Biosciences as part of broader spending spree Read more: Novartis buys Avidity Biosciences as part of broader spending spree
Responsible sourcing programmes of chocolate companies have failed the stress test Read more: Responsible sourcing programmes of chocolate companies have failed the stress test
Crans-Montana: when a medical bill is not just a bill Read more: Crans-Montana: when a medical bill is not just a bill
Reality hits: hard truths come to light in the final episode of ‘Lost Cells’ Read more: Reality hits: hard truths come to light in the final episode of ‘Lost Cells’
Vote to cap Swiss population comes under international scrutiny Read more: Vote to cap Swiss population comes under international scrutiny
In Swiss-EU relations, is the era of cordiality over? Read more: In Swiss-EU relations, is the era of cordiality over?
Swiss deeply divided on ten million population cap Read more: Swiss deeply divided on ten million population cap
The SWIplus app: your connection to Switzerland Read more: The SWIplus app: your connection to Switzerland
Demographics Federer, the play "In love with Federer" is a play produced by a small theatre company in Geneva. The two actors didn’t try to "play" Federer, but rather focused on how the tennis legend affects television viewers. (RTS/swissinfo.ch) This content was published on March 10, 2013 - 15:48 1 minute Popular Stories Most Discussed You can find an overview of ongoing debates with our journalists here . Please join us! If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch. Read more
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.